Changeflow GovPing Government General AngioDynamics AccuVu Angiographic Catheter Reca...
Urgent Enforcement Amended Final

AngioDynamics AccuVu Angiographic Catheter Recall - Guidewire Passage Defect

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

FDA Class II recall initiated by AngioDynamics, Inc. for AccuVu Angiographic Catheters due to a manufacturing defect that may prevent appropriately sized guidewires from passing through the catheter hub inner diameter. The firm initiated the voluntary recall on March 3, 2026, after determining the cause as nonconforming material or component. Affected products include Lot No. A2825044 across Catalog No. 13709604, totaling 65 units distributed domestically and internationally to 22 countries.

“The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub.”

FDA , verbatim from source
Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

AngioDynamics initiated a voluntary Class II recall of AccuVu Angiographic Catheters (Catalog No. 13709604, Lot A2825044) after identifying a manufacturing defect that may prevent guidewire passage through the catheter hub. FDA classified this as a Class II recall representing a situation in which use of or exposure to a violative product may cause temporary or medically reversible health consequences. Healthcare facilities with affected catheters in inventory must immediately cease use, segregate the product, and return it to AngioDynamics. The recall affects 65 units distributed to US facilities and 21 international markets including Austria, Australia, Canada, Germany, Ireland, Italy, and others.

What to do next

  1. Stop using the devices subject to this recall and share the notification to all users of the devices within your facility immediately.
  2. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping and Receiving or ANY other location).
  3. Package and Return the Recalled Product.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall Angiodynamics AccuVu

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall Angiodynamics AccuVu | |

Date Initiated by Firm March 03, 2026
Date Posted April 17, 2026
Recall Status Open , Classified
Recall Number Z-1873-2026
Recall Event ID 98463
510(K)Number K112452 K161596
Product Classification Catheter, intravascular, diagnostic - Product Code DQO
Product AccuVu Angiographic Catheter, Straight Flush, Non-Braided, With 10 R/O Markers;

ACCU-VU STR FL 4F X 100CM 035 NB 6SH 10 R/O 6@1CM 4@5CM;
Catalog No.: 13709604;
Product/UPN No.: H787137096045 (Box), H787137096040 (Pouch);
Box Quantity: 5 pouches; |
| Code Information | ACCU-VU STR FL 4F X 100CM 035 NB 6SH 10 R/O 6@1CM 4@5CM;
Catalog No.: 13709604;
Product/UPN No.: H787137096045 (Box), H787137096040 (Pouch);
UDI-DI: 25051684005996(Box), 15051684005999(Pouch);
Lot No.: A2825044; |
| FEI Number | 1319211 |
| Recalling Firm/
Manufacturer | Angiodynamics, Inc.
603 Queensbury Ave
Queensbury NY 12804-7619 |
| For Additional Information Contact | Kasey Newcomb
978-333-1108 |
| Manufacturer Reason
for Recall | The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub. |
| FDA Determined
Cause | Nonconforming Material/Component |
| Action | On March 3, 2026 URGENT VOLUNTARY MEDICAL DEVICE RECALL letters were sent to customers.
Actions to be taken:
IMMEDIATELY:
1. Stop using the devices subject to this recall and share the notification to all users of the deviceswithin your facility immediately.
2. Provide a copy of this recall notification to all sites or clinics to which you have distributed affectedproduct.
3. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping andReceiving or ANY other location).
4. Segregate this product in a secure location for return to AngioDynamics, Inc.
5. Package and Return the Recalled Product. |
| Quantity in Commerce | 65 units (13 boxes) |
| Distribution | Worldwide distribution - US Nationwide and the countries of Austria, Australia, Belgium, Canada, China, Chile, Curacao, Czech Republic, Germany, Ireland, Israel, Italy, Lebanon, Netherlands, New Zealand, Panama, Slovenia, South Africa, Spain, Sweden, Thailand. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

| 510(K) Database | 510(K)s with Product Code = DQO |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 3rd, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1873-2026

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall response Product return procedures
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!